Deltagen Reports Full-Year 2006 Consolidated Financial Results and ...
Deltagen, Inc. (Pink Sheets:DGEN), a leading provider of drug discovery tools to the biopharmaceutical industry, today reported audited financial results for the year ended December 31, 2006 and declared a 5-cent per share dividend scheduled to be distributed on or about May 31, 2007 to shareholders of record as of the close of business on May 21, 2007.
Revenues: The Company's consolidated revenues for the year ended December 31, 2006 totaled $9.780 million. The revenues were attributable primarily to: (i) license fees associated with the provision of knockout mice and related phenotypic data under the Company's DeltaOne(TM) program; (ii) fees associated with the acceptance by the NIH of materials relating to the initial delivery order placed by the NIH in September 2005; and (iii) milestone buyout payments from two of the Company's DeltaBase subscribers, which were received during the fourth quarter of 2006.
没有评论:
发表评论